TESCTS concerns about the unsustainabiity of health systems in Europe, it is necessary to look at the broader needs of our society.
An ageing, co-morbid population needs special attention with a clear focus on the role of prevention. We are joined partner to “Patient and citizen Empowerment across the EIP Action”, A1.
To generate a scientific base for the society and the clinical research and health economy actors to understand, treat and prevent age-related neurological diseases with advanced technologies.
The Trans European Stem Cell Therapy Society (TESCT) was founded in 2005 by Dr. Marco Traub PHD in Switzerland to encourage the speedy transfer of stem cell technology from laboratory translation to clinical practice with the focus on the patient and the improvement of the Life Quality.
Together with Rosie Graham from London the TESCT Society was formed to an expert forum and arranged milestone meetings at the Royal Academy of Medicine London and the University of Dakar and University of Ljubljana and the European Commission, Brussels.
Copyright © 2019 TESCT. Developed by BayState InfoTech.